Vital Therapies, Inc. (NasdaqGS:VTL) currently has a 10-year dividend growth rate of -99.90%. This number is calculated using the geometric average which provides the typical value of dividend growth over the specified period using the product of their values. The geometric average is defined as the nth root of the product of n numbers. Solid dividend growth may be one sign of a healthy stock.

Investors may be watching different time periods to assess dividend growth rates. The stock currently has an 8 year dividend growth rate of -99.90%, a 5 year of -99.90%, and a 3 year of 0.00%.

Free Cash Flow or **FCF**, may be used to gauge the true profitability of a company. FCF measures the amount of cash a company generates after accounting for capital expenditures, and it may be a useful indicator for assessing financial performance. Vital Therapies, Inc. (NasdaqGS:VTL)‘s FCF growth is presently at 0.579439.

This is calculated by subtracting FCF from the previous year from FCF this year, divided by FCF from last year. The company has an FCF score of 1.208551. The FCF score is an indicator that is derived by combining free cash flow stability with free cash flow growth. In general, a higher FCF score value would signal high free cash flow growth.

The current FCF quality score is -2.914192. The free quality score assists with estimating free cash flow stability. FCF quality is calculated as the 12 ltm cash flow per share over the average of the cash flow numbers.

With this number, a lower ratio is typically preferred. Looking a bit further, the company has an FCF yield of -0.559157, and a 5-year average FCF yield of -0.408819. The first is simply FCF divided by enterprise value, and the second is the five year average FCF divided by the current enterprise value.

**SMA Cross**Technical traders and investors may be looking at the simple moving average 50/200 cross on shares of Vital Therapies, Inc. (NasdaqGS:VTL). At the time of writing, the SMA 50/200 Cross value is 0.74383.

If the value is greater than one, the 50 day moving average is above the 200 day moving average, which may signal positive stock price momentum. A value less than one would indicate that the 50 day moving average is below the 200 day, which may indicate negative share price momentum.

**Range**

Investors often keep track of key stock price levels when doing equity research. Two standard levels are the 52-week high and 52-week low. Shares tend to come under increased scrutiny when approaching either of the two marks. After a recent check, the current stock price divided by the 52-week high for shares of Vital Therapies, Inc. (NasdaqGS:VTL), gives us a value of 0.481.